A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually
Published:
August 17, 2022
by Xinhua News Agency
|
Seventy percent of patients concerned about tobacco corporations’ ownership of lung disease treatments; treatments include inhalers, medications, other devices
Published:
August 16, 2022
by Business Wire
|
Sanofi, UK National Institute for Health and Care Research enrolling patients for clinical trial to evaluate injectable drug nirsevimab’s protection against respiratory syncytial virus in infants; trial to involve 20,000 infants in UK, France, Germany
Published:
August 16, 2022
by SeeNews Pharmaceuticals
|
Global bronchitis treatment market projected to grow by US$1.1B, have CAGR growth of 4.76%, from 2021 to 2026; growth driven by increase in smoking, as 32.51 million people smoked in US in 2020, 3.7 million smoke in Canada: Technavio
Published:
August 02, 2022
by PR Newswire
|
Novartis cancels filing for FDA approval of tislelizumab to treat non-small cell lung cancer after FDA decision to delay review of drug as esophageal squamous cell carcinoma treatment; Novartis paid BeiGene US$650M for rights to drug outside China
Published:
August 02, 2022
by Indian Pharma Industry : Policies
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count